Invention Grant
- Patent Title: Quinolines as FGFR kinase modulators
-
Application No.: US15205676Application Date: 2016-07-08
-
Publication No.: US10039759B2Publication Date: 2018-08-07
- Inventor: Valerio Berdini , Patrick René Angibaud , Steven John Woodhead , Gordon Saxty
- Applicant: ASTEX THERAPEUTICS LIMITED
- Applicant Address: GB Cambridge
- Assignee: ASTEX THERAPEUTICS LTD
- Current Assignee: ASTEX THERAPEUTICS LTD
- Current Assignee Address: GB Cambridge
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB1118652.5 20111028
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; C07D401/14 ; C07D413/14 ; C07D215/38 ; C07D401/04 ; C07D407/14 ; A61K31/47 ; A61K31/506 ; A61K31/5377 ; A61K45/06 ; C07D405/14
Abstract:
The invention relates to new quinoline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Public/Granted literature
- US20170000781A1 QUINOLINES AS FGFR KINASE MODULATORS Public/Granted day:2017-01-05
Information query
IPC分类:
